Key Points
- Neonc president Amir Heshmatpour bought 6,000 shares at $6.51 each on Nov. 24 for $39,060, bringing his total ownership to 2,992,000 shares (a ~0.20% increase) valued at roughly $19.48 million.
- Shares recently jumped (headline noted a 24.9% rise) and opened at $7.32, but the company reported a ($0.45) EPS loss for the quarter and analysts—including Weiss Ratings—maintain a consensus "Sell" rating.
Neonc Technologies Holdings, Inc. (NASDAQ:NTHI - Get Free Report) President Amir Heshmatpour bought 6,000 shares of the company's stock in a transaction on Monday, November 24th. The shares were purchased at an average cost of $6.51 per share, for a total transaction of $39,060.00. Following the transaction, the president owned 2,992,000 shares in the company, valued at approximately $19,477,920. This represents a 0.20% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.
Neonc Technologies Stock Up 24.9%
Shares of NTHI opened at $7.32 on Tuesday. The stock has a 50 day moving average of $10.04 and a 200 day moving average of $7.45. Neonc Technologies Holdings, Inc. has a 12 month low of $3.20 and a 12 month high of $25.00.
Neonc Technologies (NASDAQ:NTHI - Get Free Report) last posted its quarterly earnings data on Friday, November 14th. The company reported ($0.45) earnings per share for the quarter.
Analyst Ratings Changes
Separately, Weiss Ratings restated a "sell (e)" rating on shares of Neonc Technologies in a report on Wednesday, October 8th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the stock currently has a consensus rating of "Sell".
Read Our Latest Stock Analysis on NTHI
Institutional Inflows and Outflows
A number of institutional investors have recently made changes to their positions in NTHI. HCR Wealth Advisors bought a new position in shares of Neonc Technologies during the 2nd quarter worth $54,000. Foundations Investment Advisors LLC purchased a new stake in Neonc Technologies during the third quarter valued at about $100,000. SLT Holdings LLC bought a new position in Neonc Technologies during the third quarter worth about $100,000. LVW Advisors LLC bought a new stake in shares of Neonc Technologies in the second quarter valued at approximately $108,000. Finally, Royal Bank of Canada purchased a new stake in shares of Neonc Technologies during the 1st quarter valued at approximately $247,000.
Neonc Technologies Company Profile
(
Get Free Report)
Neonc Technologies Holdings, Inc develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. Its lead products in development include NEO100, which is in Phase 2a clinical trials for treating glioblastoma; and NEO212, a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol that is completed preclinical testing.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
